Mubadala and GIC, the sovereign wealth funds of Abu Dhabi and Singapore, are in talks for a joint takeover of Spanish REIT Healthcare Activos Yield just nine months after it listed in Paris.
The ophthalmic services M&A market is heating up across Europe as investors envisage a largely COVID-free 2022. HBI has been speaking to operators to find out the latest on known deals and rumours circulating at the moment.
Korian, the major pan-European elder care group, continues its consolidation of the mental health sector in France. It has just entered exclusive negotiations to acquire the Osny psychotherapy centre based in the Paris region. HBI looks at this, and other recent acquisitions.
Hospital admissions for A&E patients have not yet returned to their pre-Covid levels in Western Europe, despite significant increases in attendance since January this year.
HBI hears that Antin Infrastructure Partners is considering the sale of Almaviva Sante, the fourth largest French hospital group by revenue. HBI speaks to a France-based consultant to find out more and to talk about potential suitors.
The management of DomusVi, the pan-European nursing home group, backed by DomusVi founder Yves Journel's investment vehicle, have bought out private equity firm ICG in a leveraged buyout. The group was reportedly valued at €4.3bn, 16.4 times adjusted 2020 EBITDA.
Across Europe care home operators are optimistic about recovery, with many saying they expect a return to something like normality by the end of 2021. Is this too optimistic? HBI looks at France-based Orpea and Korian, and talks to a market expert to find out more.
Icade will separately list its healthcare division Icade Santé on the Euronext by the end of this year, becoming Europe's largest healthcare-only REITs. The news comes as Aedifica singles out healthcare as the main spending target of a new €287m raise.
This week HBI breaks down data from several sources and illustrates the share of informal homecare in European Countries and the UK. It makes clear just how much care at home is being illegally delivered.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
